【Congratulations】 TGP Alumni FaceHeart Inc Leads the World by Passing the FDA's Strict Challenges
Artificial intelligence (AI) startup FaceHeart Inc. officially announced today that its heart rate monitoring software, FaceHeart Vitals™ SDK, has been officially cleared by the U.S. Food and Drug Administration (FDA) as a Class II SaMD (Software as a Medical Device) on September 1, 2023, making it the world's first FDA-cleared product to measure heart rate using a regular camera image. The software can access physiological information simply through the front lens of a smartphone or the video lens of a tablet, enabling rapid deployment of scenarios such as telemedicine, silver-haired smart care, and remote patient monitoring, and realizing the vision of popularizing smart healthcare. In addition, FaceHeart Inc. continues to work toward FDA and EU medical certifications for imaging measurements of physiological information such as respiration, oximetry, and blood pressure, accelerating the expansion of its services into the smart healthcare landscape across multiple markets. {From Mirror Media TGP Alumni FaceHeart Inc Leads the World by Passing the FDA's Strict Challenges (mirrormedia.mg)}
News References:
Mirror Media TGP Alumni FaceHeart Inc Leads the World by Passing the FDA's Strict Challenges (mirrormedia.mg)